Literature DB >> 10640748

Cell-mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant.

A La Cava1, R Billetta, G Gaietta, D B Bonnin, S M Baird, S Albani.   

Abstract

After intradermal genetic immunization, naked DNA is transported from the site of injection to regional lymph nodes. Little is known on how inflammation influences this process and whether DNA is transported beyond local lymph nodes. In the experiments herein reported, we injected naked DNA in the presence of adjuvant to address questions related to 1) the fate of naked DNA in the presence of inflammation; 2) the generation of immune responses to the encoded protein during inflammation; and, more in general, 3) the fate of ingested molecules beyond regional lymph nodes during inflammation. Two sites of inflammation were induced in vivo in mice. Naked DNA was injected in the nape together with adjuvant, and adjuvant only was injected at a distant peritoneal site. Injected DNA, uptaken at the primary dermal site of inflammation, was transported beyond regional lymph nodes to distant organs such as the spleen and to the distant peritoneal site of inflammation. This transport, mediated by CD11b+ cells, was cumulative during chronic inflammation. These results indicate a novel route of transport of DNA beyond regional lymph nodes and may have specific implications for DNA-based immune modulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640748     DOI: 10.4049/jimmunol.164.3.1340

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Gene therapy and wound healing.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

2.  Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.

Authors:  B R Lawson; G J Prud'homme; Y Chang; H A Gardner; J Kuan; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization.

Authors:  Hye-Youn Son; Hwan-Kyu Jeong; Vasso Apostolopoulos; Chul-Woo Kim
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

4.  Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases.

Authors:  Mika Kamata; Kaori Denda-Nagai; Nobuyoshi Kubota; Satoshi Aida; Kazuyoshi Takeda; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery.

Authors:  A A M Coelho-Castelo; A P Trombone; R S Rosada; R R Santos; V L D Bonato; A Sartori; C L Silva
Journal:  Genet Vaccines Ther       Date:  2006-01-30

6.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.

Authors:  A N Theofilopoulos; S Koundouris; D H Kono; B R Lawson
Journal:  Arthritis Res       Date:  2001-02-14

7.  B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.

Authors:  Viswa Teja Colluru; Douglas G McNeel
Journal:  Oncotarget       Date:  2016-10-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.